Valuation Exelixis, Inc. Berne S.E.

Stocks

End-of-day quote Berne S.E. 30/09/2026			5-day change	1st Jan Change
50.33 ^CHF	+4.05%		+3.74%	-

09-15	Exelixis, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 11:30 AM
09-11	Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday Amid Inflation Data Release	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	5,784	5,174	7,460	9,510	11,799	14,532	-	-
Change	-	-10.54%	44.19%	27.47%	24.07%	23.16%	-	-
Enterprise Value (EV) ¹	4,317	3,865	6,465	8,399	10,740	13,788	12,910	11,785
Change	-	-10.45%	67.25%	29.91%	27.88%	28.38%	-6.37%	-8.71%
P/E	25.4x	28.6x	36.9x	18.9x	15.8x	18.1x	15x	11.5x
PBR	2.64x	2.09x	3.21x	4.18x	5.32x	5.58x	4.1x	3.04x
PEG	-	-1.3x	2.3x	0x	0.3x	1.1x	0.7x	0.4x
Capitalization / Revenue	4.03x	3.21x	4.08x	4.39x	5.09x	5.69x	5x	4.38x
EV / Revenue	3.01x	2.4x	3.53x	3.87x	4.63x	5.4x	4.44x	3.55x
EV / EBITDA	14.4x	17.4x	32.9x	13.3x	11.9x	12.6x	10.2x	7.39x
EV / EBIT	15.1x	19.2x	37.8x	13.9x	12.3x	13.4x	10.1x	7.5x
EV / FCF	12.8x	17.2x	22.1x	12.5x	12.3x	16.7x	15.9x	8.47x
FCF Yield	7.8%	5.8%	4.53%	8%	8.15%	5.99%	6.29%	11.8%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	0.72	0.56	0.65	1.76	2.78	3.238	3.914	5.119
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	1,435	1,611	1,830	2,169	2,320	2,555	2,906	3,315
EBITDA ¹	300.3	222.4	196.6	633.4	901.2	1,093	1,261	1,595
EBIT ¹	286.7	201.5	170.9	604.6	872.2	1,032	1,278	1,572
Net income ¹	231.1	182.3	207.8	521.3	782.6	820.7	1,012	1,248
Net Debt ¹	-1,467	-1,308	-995.3	-1,111	-1,059	-744.5	-1,623	-2,747
Reference price ²	18.28	16.04	23.99	33.30	43.83	58.65	58.65	58.65
Nbr of stocks (in thousands)	316,397	322,561	310,974	285,579	269,203	247,782	-	-
Announcement Date	17/02/22	07/02/23	06/02/24	11/02/25	10/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
WUXI APPTEC CO., LTD.	20.87x	7.45x	14.96x	1.42%	71.53B
ARGENX SE	31.24x	9x	28.05x	0.04%	60.12B
LONZA GROUP AG	34.13x	6.11x	18.31x	0.95%	48.85B
IQVIA HOLDINGS INC.	34.64x	3.34x	14.41x	-.--%	44.28B
REVOLUTION MEDICINES, INC.	-21.08x	228.26x	-22.72x	-.--%	43.83B
BEONE MEDICINES AG	47.85x	5.53x	30.37x	-.--%	41.53B
CELLTRION, INC.	27.07x	7.8x	20.09x	0.42%	30.13B
WUXI BIOLOGICS (CAYMAN) INC.	32.39x	6.91x	17.94x	-.--%	27.98B
INSMED INCORPORATED	-70.94x	13.62x	-69.42x	-.--%	25.25B
Average	15.13x	32.00x	5.78x	0.32%	43.72B
Weighted average by Cap.	19.23x	31.83x	9.93x	0.42%